Status:
COMPLETED
Photoprovocation Testing in Subjects With Cutaneous Lupus
Lead Sponsor:
University of Pennsylvania
Conditions:
Lupus Erythematosus
Photosensitivity Conditions
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Photosensitivity is well documented among lupus patients and is one of the diagnostic criteria for systemic lupus erythematosus (SLE). Photosensitivity is highly prevalent in lupus and has a wide rang...
Eligibility Criteria
Inclusion
- Participants who have a diagnosis of CLE based on either the Gilliam classification of DLE and SCLE, or SLE based on the American College of Rheumatology criteria.
Exclusion
- Participants who do not meet criteria for either CLE or SLE.
- Participants with a diagnosis of Erythropoietic Protoporphyria and Solar Urticaria, or another photodermatoses other than Polymorphous light eruption.
- Participants who are not yet 18 years old or who are not capable of giving written informed consent prior to enrolling in the study.
- Participants who have undergone any recent phototesting, or phototherapy exposure, or those who are suspected of having a drug-induced photosensitivity.
- Female participants who are pregnant or breastfeeding will be excluded from the study. This will be determined by patient self-reporting.
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2018
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT01516788
Start Date
December 1 2011
End Date
July 2 2018
Last Update
July 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104